ApoGen Biotechnologies' Series A Round

ApoGen Biotechnologies raised a round of funding on December 08, 2016.

ApoGen Biotechnologies is a biotechnology company focused on the development of a new class of therapeutics targeting drivers of cancer genomic mutation. ApoGen is building upon technologies developed…

Articles about ApoGen Biotechnologies' Series A Round: